{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:03:19Z","timestamp":1790996599590,"version":"4.1.0"},"reference-count":85,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:sec>\n<jats:title>OBJECT<\/jats:title>\n<jats:p>Unilateral subthalamotomy is a surgical procedure that may be used to alleviate disabling levodopa-induced dyskinesias (LIDs) in patients with Parkinson disease (PD). However, the mechanisms involved in LID remain largely unknown. The subthalamic nucleus (STN) is the sole glutamatergic nucleus within the basal ganglia, and its lesion may produce changes in glutamate receptors in various areas of the basal ganglia. The authors aimed to investigate the biochemical changes in glutamate receptors in striatal and pallidal regions of the basal ganglia after lesion of the STN in parkinsonian macaque monkeys.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>The authors treated 12 female ovariectomized monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to induce PD-like symptoms, treated 8 of these animals with 3,4-dihydroxy-<jats:sc>l<\/jats:sc>-phenylalanine (L-DOPA; levodopa) to induce LID, and performed unilateral subthalamotomy in 4 of these 8 monkeys. Four additional monkeys were treated with saline only and were used as controls. The MPTP monkeys had previously been shown to respond behaviorally to lower doses of levodopa after the STN lesion. Autoradiography of slices from postmortem brain tissues was used to visualize changes in the specific binding of striatal and pallidal ionotropic glutamate receptors (that is, of the \u03b1-amino-3-hydroxy 5-methyl-4-isoxazole propionate [AMPA] and <jats:italic>N<\/jats:italic>-methyl-<jats:sc>d<\/jats:sc>-aspartate [NMDA] NR1\/NR2B subunit receptors) and of metabotropic glutamate (mGlu) receptors (that is, mGlu2\/3 and mGlu5 receptors). The specific binding and distribution of glutamate receptors in the basal ganglia of the levodopa-treated, STN-lesioned MPTP monkeys were compared with those in the saline-treated control monkeys and in the saline-treated and levodopa-treated MPTP monkeys.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>The autoradiographic results indicated that none of the pharmacological and surgical treatments produced changes in the specific binding of AMPA receptors in the basal ganglia. Levodopa treatment increased the specific binding of NMDA receptors in the basal ganglia. Subthalamotomy reversed these increases in the striatum, but in the globus pallidus (GP), the subthalamotomy reversed these increases only contralaterally. Levodopa treatment reversed MPTP-induced increases in mGlu2\/3 receptors only in the GP. mGlu2\/3 receptor\u2013specific binding in the striatum and GP decreased bilaterally in the levodopa-treated, STN-lesioned MPTP monkeys compared with the other 3 groups. Compared with mGlu5 receptor\u2013specific binding in the control monkeys, that of the levodopa-treated MPTP monkeys increased in the dorsal putamen and remained unchanged in the caudate nucleus and in the GP.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>These results implicate glutamate receptors in the previously observed benefits of unilateral subthalamotomy to improve motor control.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2014.10.jns141570","type":"journal-article","created":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T13:59:56Z","timestamp":1430488796000},"page":"1383-1393","source":"Crossref","is-referenced-by-count":8,"title":["Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy"],"prefix":"10.3171","volume":"123","author":[{"given":"Vincent A.","family":"Jourdain","sequence":"first","affiliation":[{"name":"Neuroscience Research Unit, Centre Hospitalier Universitaire de Qu\u00e9bec; and"},{"name":"Faculty of Pharmacy, Laval University, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Morin","sequence":"additional","affiliation":[{"name":"Neuroscience Research Unit, Centre Hospitalier Universitaire de Qu\u00e9bec; and"},{"name":"Faculty of Pharmacy, Laval University, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gr\u00e9goire","sequence":"additional","affiliation":[{"name":"Neuroscience Research Unit, Centre Hospitalier Universitaire de Qu\u00e9bec; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Morissette","sequence":"additional","affiliation":[{"name":"Neuroscience Research Unit, Centre Hospitalier Universitaire de Qu\u00e9bec; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Di Paolo","sequence":"additional","affiliation":[{"name":"Neuroscience Research Unit, Centre Hospitalier Universitaire de Qu\u00e9bec; and"},{"name":"Faculty of Pharmacy, Laval University, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns141570","series-title":"J Pharmacol Exp Ther","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1124\/jpet.106.105387","article-title":"Pharmacological stimulation of group II metabotropic glutamate receptors reduces cocaine self-administration and cocaine-induced reinstatement of drug seeking in squirrel monkeys","volume":"318","author":"Adewale","year":"2006"},{"key":"b2-jns141570","series-title":"The Glutamate Receptors","first-page":"1","article-title":"AMPA receptors","author":"Ashby","year":"2008"},{"key":"b3-jns141570","series-title":"J Neurosci","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1523\/JNEUROSCI.20-21-07871.2000","article-title":"Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus","volume":"20","author":"Awad","year":"2000"},{"key":"b4-jns141570","series-title":"Neuropharmacology","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0028-3908(03)00146-1","article-title":"Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"45","author":"Battaglia","year":"2003"},{"key":"b5-jns141570","series-title":"Pharmacol Biochem Behav","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.pbb.2009.08.011","article-title":"Interactions between the mGluR2\/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys","volume":"94","author":"Bauzo","year":"2009"},{"key":"b6-jns141570","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/mds.23616","article-title":"AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials","volume":"26","author":"Berg","year":"2011"},{"key":"b7-jns141570","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.expneurol.2005.08.017","article-title":"Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD","volume":"196","author":"Bibbiani","year":"2005"},{"key":"b8-jns141570","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/mds.870130507","article-title":"Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys","volume":"13","author":"Blanchet","year":"1998"},{"key":"b9-jns141570","series-title":"J Pharmacol Exp Ther","first-page":"1034","article-title":"Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys","volume":"290","author":"Blanchet","year":"1999"},{"key":"b10-jns141570","series-title":"Expert Opin Investig Drugs","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1517\/13543784.2012.651457","article-title":"New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors","volume":"21","author":"Blandini","year":"2012"},{"key":"b11-jns141570","series-title":"Neurosci Lett","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0304-3940(95)11292-5","article-title":"Autoradiographic study of mitochondrial complex I and glutamate receptors in the basal ganglia of rats after unilateral subthalamic lesion","volume":"186","author":"Blandini","year":"1995"},{"key":"b12-jns141570","series-title":"Prog Neuropsychopharmacol Biol Psychiatry","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0278-5846(01)00237-8","article-title":"Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment","volume":"26","author":"Calon","year":"2002"},{"key":"b13-jns141570","series-title":"Neurobiol Dis","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2003.07.003","article-title":"Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease","volume":"14","author":"Calon","year":"2003"},{"key":"b14-jns141570","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(81)91113-6","article-title":"Connections of the subthalamic nucleus in the monkey","volume":"224","author":"Carpenter","year":"1981"},{"key":"b15-jns141570","series-title":"Am J Anat","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/aja.1001210105","article-title":"Efferent fibers of the subthalamic nucleus in the monkey. A comparison of the efferent projections of the subthalamic nucleus, substantia nigra and globus pallidus","volume":"121","author":"Carpenter","year":"1967"},{"key":"b16-jns141570","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.neuroscience.2005.03.006","article-title":"Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism","volume":"133","author":"Centonze","year":"2005"},{"key":"b17-jns141570","series-title":"Parkinsons Dis","first-page":"190450","article-title":"Neuroprotection and functional recovery associated with decreased microglial activation following selective activation of mGluR2\/3 receptors in a rodent model of Parkinson's disease","volume":"2010","author":"Chan","year":"2010"},{"key":"b18-jns141570","series-title":"Nat Rev Neurosci","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nrn1763","article-title":"Metabotropic glutamate receptors in the basal ganglia motor circuit","volume":"6","author":"Conn","year":"2005"},{"key":"b19-jns141570","series-title":"Trends Neurosci","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","article-title":"Primate models of movement disorders of basal ganglia origin","volume":"13","author":"DeLong","year":"1990"},{"key":"b20-jns141570","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1300962","article-title":"A pilot study of focused ultrasound thalamotomy for essential tremor","volume":"369","author":"Elias","year":"2013"},{"key":"b21-jns141570","series-title":"Parkinsonism Relat Disord","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.parkreldis.2013.01.009","article-title":"Safinamide reduces dyskinesias and prolongs L-DOPA antiparkinsonian effect in parkinsonian monkeys","volume":"19","author":"Gr\u00e9goire","year":"2013"},{"key":"b22-jns141570","series-title":"Parkinsonism Relat Disord","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.parkreldis.2011.01.008","article-title":"The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in L-Dopa-treated parkinsonian monkeys","volume":"17","author":"Gr\u00e9goire","year":"2011"},{"key":"b23-jns141570","series-title":"Prog Neurobiol","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.pneurobio.2004.09.005","article-title":"Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases","volume":"74","author":"Gubellini","year":"2004"},{"key":"b24-jns141570","series-title":"Brain","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/brain\/119.5.1717","article-title":"Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis","volume":"119","author":"Guridi","year":"1996"},{"key":"b25-jns141570","series-title":"Neurobiol Dis","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.nbd.2003.10.007","article-title":"Effect of a selective glutamate antagonist on Ldopa-induced dyskinesias in drug-naive parkinsonian monkeys","volume":"15","author":"Hadj Tahar","year":"2004"},{"key":"b26-jns141570","series-title":"Stereotact Funct Neurosurg","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000120426","article-title":"Clinical cases where lesion therapy was chosen over deep brain stimulation","volume":"86","author":"Hooper","year":"2008"},{"key":"b27-jns141570","series-title":"Eur J Neurosci","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1111\/j.1460-9568.2005.04169.x","article-title":"Immunoautoradiographic analysis of NMDA receptor subunits and associated postsynaptic density proteins in the brain of dyskinetic MPTP-treated common marmosets","volume":"21","author":"Hurley","year":"2005"},{"key":"b28-jns141570","series-title":"J Pharmacol Exp Ther","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1124\/jpet.110.166629","article-title":"Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease","volume":"333","author":"Johnston","year":"2010"},{"key":"b29-jns141570","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3171\/2012.9.JNS12295","article-title":"Potentiation of response to low doses of levodopa in MPTP-injected monkeys by chemical unilateral subthalamotomy","volume":"118","author":"Jourdain","year":"2013"},{"key":"b30-jns141570","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.expneurol.2014.08.018","article-title":"Subthalamotomy-induced changes in dopamine receptors in parkinsonian monkeys","volume":"261","author":"Jourdain","year":"2014"},{"key":"b31-jns141570","series-title":"Stereotact Funct Neurosurg","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000355215","article-title":"Health economics and surgical treatment for Parkinson's disease in a world perspective: results from an international survey","volume":"92","author":"Jourdain","year":"2014"},{"key":"b32-jns141570","series-title":"J Comp Neurol","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cne.902600309","article-title":"Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method","volume":"260","author":"Kita","year":"1987"},{"key":"b33-jns141570","series-title":"Naunyn Schmiedebergs Arch Pharmacol","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/PL00005284","article-title":"LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats","volume":"358","author":"Konieczny","year":"1998"},{"key":"b34-jns141570","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1212\/WNL.54.8.1589","article-title":"AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys","volume":"54","author":"Konitsiotis","year":"2000"},{"key":"b35-jns141570","series-title":"Naunyn Schmiedebergs Arch Pharmacol","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s002109900199","article-title":"Activation of striatal group II metabotropic glutamate receptors has a differential effect on dopamine-D1 and -D2 receptor antagonist-induced hypokinesia in the rat","volume":"361","author":"Kronthaler","year":"2000"},{"key":"b36-jns141570","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0006-8993(75)90384-4","article-title":"Bilateral projections from precentral motor cortex to the putamen and other parts of the basal ganglia. An autoradiographic study in Macaca fascicularis","volume":"88","author":"K\u00fcnzle","year":"1975"},{"key":"b37-jns141570","series-title":"Exp Brain Res","first-page":"481","article-title":"Projections from the primary somatosensory cortex to basal ganglia and thalamus in the monkey","volume":"30","author":"K\u00fcnzle","year":"1977"},{"key":"b38-jns141570","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.expneurol.2011.10.018","article-title":"A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro","volume":"233","author":"Ledonne","year":"2012"},{"key":"b39-jns141570","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/mds.23983","article-title":"Perampanel, an AMPA antagonist, found to have no benefit in reducing \u201coff\u201d time in Parkinson's disease","volume":"27","author":"Lees","year":"2012"},{"key":"b40-jns141570","series-title":"Neurobiol Dis","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.nbd.2007.08.011","article-title":"Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease","volume":"29","author":"Levandis","year":"2008"},{"key":"b41-jns141570","series-title":"Primate Brain Maps: Structure of the Macaque Brain","author":"Martin","year":"2000"},{"key":"b42-jns141570","series-title":"Arch Neurol","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/archneur.56.11.1383","article-title":"Amantadine for levodopa-induced dyskinesias: a 1-year follow-up study","volume":"56","author":"Metman","year":"1999"},{"key":"b43-jns141570","series-title":"Brain","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/brain\/108.2.405","article-title":"Subcortical changes in the regional uptake of [3H]-2-deoxyglucose in the brain of the monkey during experimental choreiform dyskinesia elicited by injection of a gamma-aminobutyric acid antagonist into the subthalamic nucleus","volume":"108","author":"Mitchell","year":"1985"},{"key":"b44-jns141570","series-title":"Neuropharmacology","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.neuropharm.2009.12.024","article-title":"Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys","volume":"58","author":"Morin","year":"2010"},{"key":"b45-jns141570","series-title":"Neuropharmacology","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.neuropharm.2012.07.036","article-title":"MPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates","volume":"66","author":"Morin","year":"2013"},{"key":"b46-jns141570","series-title":"Neuropharmacology","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.neuropharm.2013.05.028","article-title":"Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys","volume":"73","author":"Morin","year":"2013"},{"key":"b47-jns141570","series-title":"Proc Natl Acad Sci U S A","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1073\/pnas.0500914102","article-title":"Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice","volume":"102","author":"Morishima","year":"2005"},{"key":"b48-jns141570","series-title":"Pharmacol Biochem Behav","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0091-3057(02)00842-0","article-title":"Evaluation of the mGluR2\/3 agonist LY379268 in rodent models of Parkinson's disease","volume":"73","author":"Murray","year":"2002"},{"key":"b49-jns141570","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.expneurol.2004.05.004","article-title":"The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease","volume":"188","author":"Nash","year":"2004"},{"key":"b50-jns141570","series-title":"PLoS ONE","doi-asserted-by":"publisher","first-page":"e55706","DOI":"10.1371\/journal.pone.0055706","article-title":"Striatal glutamate release in L-DOPA-induced dyskinetic animals","volume":"8","author":"Nevalainen","year":"2013"},{"key":"b51-jns141570","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/mds.22169","article-title":"Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism","volume":"23","author":"Nutt","year":"2008"},{"key":"b52-jns141570","series-title":"Neuropharmacology","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0028-3908(03)00232-6","article-title":"Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice","volume":"45","author":"O'Neill","year":"2003"},{"issue":"21 Suppl 4","key":"b53-jns141570","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","article-title":"The scientific and clinical basis for the treatment of Parkinson disease (2009)","volume":"72","author":"Olanow","year":"2009"},{"key":"b54-jns141570","series-title":"J Mol Neurosci","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s12031-008-9137-8","article-title":"Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias","volume":"38","author":"Ouattara","year":"2009"},{"key":"b55-jns141570","series-title":"J Neurochem","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1471-4159.2010.06635.x","article-title":"Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys","volume":"113","author":"Ouattara","year":"2010"},{"key":"b56-jns141570","series-title":"Neurobiol Aging","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.neurobiolaging.2009.07.014","article-title":"Metabotropic glutamate receptor type 5 in levodopa-induced motor complications","volume":"32","author":"Ouattara","year":"2011"},{"key":"b57-jns141570","series-title":"Neuroscience","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.neuroscience.2010.03.022","article-title":"Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias","volume":"167","author":"Ouattara","year":"2010"},{"key":"b58-jns141570","series-title":"Ann Neurol","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.410390505","article-title":"Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys","volume":"39","author":"Papa","year":"1996"},{"key":"b59-jns141570","series-title":"J Neurosci","doi-asserted-by":"publisher","first-page":"7659","DOI":"10.1523\/JNEUROSCI.23-20-07659.2003","article-title":"Group I metabotropic glutamate receptors in the monkey striatum: subsynaptic association with glutamatergic and dopaminergic afferents","volume":"23","author":"Paquet","year":"2003"},{"key":"b60-jns141570","series-title":"Brain Res Brain Res Rev","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0165-0173(94)00008-D","article-title":"Functional anatomy of the basal ganglia. II The place of subthalamic nucleus and external pallidum in basal ganglia circuitry","volume":"20","author":"Parent","year":"1995"},{"key":"b61-jns141570","series-title":"Neuroscience","first-page":"1139","article-title":"Localization of metabotropic glutamate receptor type 2 in the human brain","volume":"95","author":"Phillips","year":"2000"},{"key":"b62-jns141570","series-title":"Vet J","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.tvjl.2005.11.007","article-title":"The role of glutamate in central nervous system health and disease\u2014a review","volume":"173","author":"Platt","year":"2007"},{"key":"b63-jns141570","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0006-8993(93)90257-N","article-title":"Excitatory amino acid receptor regulation after subthalamic nucleus lesions in the rat","volume":"602","author":"Price","year":"1993"},{"key":"b64-jns141570","series-title":"Eur J Neurosci","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1460-9568.2010.07290.x","article-title":"Forelimb dyskinesia mediated by high-frequency stimulation of the subthalamic nucleus is linked to rapid activation of the NR2B subunit of N-methyl-D-aspartate receptors","volume":"32","author":"Quintana","year":"2010"},{"key":"b65-jns141570","series-title":"Neurobiol Dis","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.nbd.2012.06.009","article-title":"Effects of LDOPA and STN-HFS dyskinesiogenic treatments on NR2B regulation in basal ganglia in the rat model of Parkinson's disease","volume":"48","author":"Quintana","year":"2012"},{"key":"b66-jns141570","series-title":"Neurobiol Dis","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.nbd.2010.05.001","article-title":"A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys","volume":"39","author":"Rylander","year":"2010"},{"key":"b67-jns141570","series-title":"J Pharmacol Exp Ther","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1124\/jpet.108.150425","article-title":"Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling","volume":"330","author":"Rylander","year":"2009"},{"key":"b68-jns141570","series-title":"J Comp Neurol","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/cne.903150203","article-title":"Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a PHA-L study of subcortical projections","volume":"315","author":"Sadikot","year":"1992"},{"key":"b69-jns141570","series-title":"Neuropharmacology","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.neuropharm.2007.08.009","article-title":"Basal ganglia group II metabotropic glutamate receptors specific binding in non-human primate model of L-Dopa-induced dyskinesias","volume":"54","author":"Samadi","year":"2008"},{"key":"b70-jns141570","series-title":"Neurobiol Aging","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.neurobiolaging.2007.02.005","article-title":"mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys","volume":"29","author":"Samadi","year":"2008"},{"key":"b71-jns141570","series-title":"J Neuropathol Exp Neurol","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/NEN.0b013e31819cabe4","article-title":"Metabotropic glutamate receptor II in the brains of Parkinsonian patients","volume":"68","author":"Samadi","year":"2009"},{"key":"b72-jns141570","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1006\/exnr.2001.7854","article-title":"Striatal AMPA receptor binding is unaltered in the MPTP-lesioned macaque model of Parkinson's disease and dyskinesia","volume":"174","author":"Silverdale","year":"2002"},{"key":"b73-jns141570","series-title":"Synapse","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/syn.20739","article-title":"Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate","volume":"64","author":"Silverdale","year":"2010"},{"key":"b74-jns141570","series-title":"J Anat","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1046\/j.1469-7580.2000.19640555.x","article-title":"GABA(B) and group I metabotropic glutamate receptors in the striatopallidal complex in primates","volume":"196","author":"Smith","year":"2000"},{"key":"b75-jns141570","series-title":"J Chem Neuroanat","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0891-0618(01)00098-9","article-title":"Ionotropic and metabotropic GABA and glutamate receptors in primate basal ganglia","volume":"22","author":"Smith","year":"2001"},{"key":"b76-jns141570","series-title":"J Comp Neurol","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/cne.902940213","article-title":"Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method","volume":"294","author":"Smith","year":"1990"},{"key":"b77-jns141570","series-title":"Brain Res Bull","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.brainresbull.2008.08.015","article-title":"The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states","volume":"78","author":"Smith","year":"2009"},{"key":"b78-jns141570","series-title":"Neuropsychopharmacology","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/npp.2011.212","article-title":"Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa","volume":"37","author":"Smith","year":"2012"},{"key":"b79-jns141570","series-title":"Exp Neurol","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/exnr.2000.7374","article-title":"Antiparkinsonian actions of CP-101,606, an antagonist of NR2B subunit-containing N-methyl-d-aspartate receptors","volume":"163","author":"Steece-Collier","year":"2000"},{"key":"b80-jns141570","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1002\/mds.25561","article-title":"AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study","volume":"28","author":"Stocchi","year":"2013"},{"key":"b81-jns141570","series-title":"J Comp Neurol","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/cne.902220208","article-title":"A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis)","volume":"222","author":"Szabo","year":"1984"},{"key":"b82-jns141570","series-title":"J Comp Neurol","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/(SICI)1096-9861(19980105)390:1<5::AID-CNE2>3.0.CO;2-6","article-title":"Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2\/3 in the rat basal ganglia","volume":"390","author":"Testa","year":"1998"},{"key":"b83-jns141570","series-title":"Neuroreport","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1097\/WNR.0b013e32832ad556","article-title":"Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum","volume":"20","author":"Walker","year":"2009"},{"key":"b84-jns141570","series-title":"Mov Disord","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/mds.23034","article-title":"Long-term antidyskinetic efficacy of amantadine in Parkinson's disease","volume":"25","author":"Wolf","year":"2010"},{"key":"b85-jns141570","series-title":"J Neurochem","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1471-4159.1992.tb09429.x","article-title":"MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates","volume":"59","author":"Zuddas","year":"1992"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/123\/6\/article-p1383.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/123\/6\/article-p1383.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/123\/6\/article-p1383.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T21:53:21Z","timestamp":1658699601000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/123\/6\/article-p1383.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":85,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2014.10.jns141570","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}